-
4 days ago | 
genomeweb.com | Justin Petrone
NEW YORK – ELIXIR this week published a paper in which it calls for new investments in data resources to support European data sovereignty in life sciences research, funding that would both position Europe as a reliable research partner as well as support innovation in artificial intelligence. Such investments could help Europe become less dependent on US funding for shared international resources, some of which have already been impacted as a result of US government cuts.
-
2 weeks ago | 
genomeweb.com | Justin Petrone
-
3 weeks ago | 
sakala.postimees.ee | Justin Petrone
Minu jaoks on lihtsalt täiesti ilmselge, et suur looduslik ala, mis asub linna keskuse lähedal, on park. Kaartidele on see aga märgitud üksnes oruna, justkui see oleks nii looduslik paik, et sellele pole ametlikku nime tarvis. Kirjutasin sõbrale, et selle paiga ajaloo kohta lähemalt uurida, ja too ütles, et peame kohtuma silmast silma: sellist infot peab ikka vahetult jagama. Kohtumiseks aega leida osutus keeruliseks.
-
4 weeks ago | 
360dx.com | Justin Petrone
NEW YORK – OncoHost, an Israeli biotechnology company, is working with three European medical centers to produce a new flow cytometry test to predict patient response to immunotherapies for five cancer indications, according to Michal Harel, OncoHost's vice president of translational medicine.
-
1 month ago | 
360dx.com | Justin Petrone
NEW YORK – A team led by investigators at Institut Pasteur has commenced work on a new lateral flow assay that could be used to detect the presence of the malaria-causing parasite Plasmodium vivax in hard to diagnose, asymptomatic individuals. The project, called PvSeroRDT (short for P. vivax Sero (as in blood) RDT, rapid diagnostic test), received €4 million ($4.5 million) from the EU earlier this year and will run through 2030.
-
1 month ago | 
360dx.com | Justin Petrone
NEW YORK – Following a recent $4.3 million financing, Upfront Diagnostics will use the proceeds to accelerate the commercialization of its lateral flow test for triaging stroke patients, LVOne, in the UK, Europe, and US, according to its CEO Gonzalo Ladreda. The Cambridge, UK-based company announced this week that it had raised the funds with Phoenix Investments, a UK investment management fund, leading the round along with Cambridge Enterprise Ventures and SBRI Healthcare.
-
2 months ago | 
360dx.com | Justin Petrone
NEW YORK – Eight German associations are calling for changes to be made to the European In Vitro Diagnostics Regulation (IVDR) in a bid to support the continued use of laboratory-developed tests. The associations, which represent geneticists, pathologists, physicians and medical laboratories, issued a statement last month, which called for several changes to the IVDR.
-
2 months ago | 
precisionmedicineonline.com | Justin Petrone
NEW YORK – Researchers in Ireland have commenced a five-year project to introduce whole-genome sequencing into pediatric cancer care. The aims of the Molecular and Genomic Interrogation of Childhood Cancer-Ireland (MAGIC-I) project are manifold and include gaining better insight into disease development as well as testing out personalized treatment approaches.
-
2 months ago | 
360dx.com | Justin Petrone
Get the full story with 360Dx Premium Only $95 for the first 90 days
-
Mar 19, 2025 | 
e-estonia.com | Justin Petrone
March 19, 2025 by Justin Petrone Article content AI Leap 2025 was inspired by Tiger Leap, a 1990s program that made internet access and computers ubiquitous in Estonian schools, laying the foundation for the country’s success in the digital sector. Policymakers believe AI Leap will familiarise Estonian students with AI technology, making the country more competitive. Several AI developers, including OpenAI and Anthropic, are already in a private-public partnership.
